The 20 Best Interstitial Keratitis Doctors Near Me in Towson, MD

Uri S. Soiberman, M.D. joined Wilmer's Cornea faculty in 2016, and is an associate professor of ophthalmology and the director of the cornea fellowship at the Wilmer Eye Institute. Dr. Soiberman's main clinical and research focus is keratoconus, and his research has been funded by the National Eye Institute and Research to Prevent Blindness. Dr. Soiberman offers his keratoconus patients advanced surgical treatments, including corneal collagen crosslinking, deep anterior lamellar keratoplasty and other types of corneal transplants for keratoconus. Dr. Soiberman also performs endothelial keratoplasty (DSEK, DMEK, DSO) for patients with Fuchs endothelial dystrophy and corneal edema. In addition, Dr. Soiberman specializes in complex cataract surgery, and offers his patients specialty intraocular lenses (such as astigmatism correcting or multifocal lenses). His surgical acumen includes surgery for dislocated lenses and secondary implantation of intraocular lenses. Dr. Soiberman is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Keratoconus, Cataract, Interstitial Keratitis, Corneal Transplant, and Vitrectomy.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as a Distinguished provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Interstitial Keratitis, Cataract, Optic Atrophy Type 1, Vitrectomy, and Cataract Removal.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis.

Amy Zimmerman is an Ophthalmologist in Lutherville Timonium, Maryland. Dr. Zimmerman is rated as a Distinguished provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Cataract, Interstitial Keratitis, Glaucoma, and Subconjunctival Hemorrhage.

Howard Hauptman is a Rheumatologist in Baltimore, Maryland. Dr. Hauptman has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Sjogren Syndrome, and Polymyalgia Rheumatica.

Sam Serafi is a Rheumatologist in Baltimore, Maryland. Dr. Serafi is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Sjogren Syndrome, and Rheumatoid Arthritis (RA).

Sezen Karakus, M.D., is an assistant professor of ophthalmology specializing in corneal and external eye diseases, with a particular focus on ocular surface conditions in patients with autoimmune and inflammatory disorders such as Sjögren's syndrome and ocular rosacea. Her expertise also extends to corneal diseases involving abnormal sensory nerves, such as neurotrophic keratitis and neuropathic corneal pain. She is skilled in performing routine and complex procedures, including cataract and intraocular lens surgeries, refractive surgeries, corneal transplants, ocular surface reconstructions and amniotic membrane transplantations. At the Wilmer Eye Institute, Johns Hopkins Medicine's Ocular Surface Diseases and Dry Eye Clinic, she plays an integral role as a team member, providing her clinical insights and expertise. Additionally, she serves as an ophthalmologist in the Postural Orthostatic Tachycardia Syndrome (POTS) program at Hopkins. This unique position allows her to address dysautonomia-related neuropathic eye pain and ocular surface diseases in patients with POTS, combining her eye specialization with a focus on this specific medical condition. As a clinician-scientist, her research revolves around ocular surface diseases. Dr. Karakus is actively investigating the role of the ocular surface microbiome in the pathogenesis of ocular rosacea. Her involvement in the NIH U24 Ocular Surface Microbiome Consortium allows her to collaborate with fellow experts in the field to standardize research methrods and develop validated protocols for studying the ocular surface microbiome. Another area of research interest for Dr. Karakus involves serological and tear biomarkers in Sjögren's disease. Through a longitudinal study, she aims to determine the utility of tissue-specific autoantibodies for early diagnosis of Sjögren's disease in patients with dry eyes. Understanding the broader impact of Sjögren's disease on the peripheral and central nervous systems is crucial, as it can manifest as severe ocular surface disease with diminished corneal sensation (neurotrophic keratitis) or intense eye pain without significant ocular surface disease (neuropathic corneal pain). Her clinical expertise and research contributions have earned Dr. Karakus recognition regionally and nationally, as evidenced by her role as a consultant in complex dry eye and ocular surface diseases. She takes pride in her dedication to advancing the understanding of ocular surface conditions and providing the best possible care for patients. By combining her specialization in corneal and external eye disease with her involvement in the POTS program and cutting-edge research on ocular surface diseases, Dr. Karakus strives to make a significant impact on patient care and contribute to the advancement of ophthalmology and related fields. Dr. Karakus is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Dry Eye Syndrome, Sjogren Syndrome, Cataract, Conjunctivitis (Pink Eye), and Corneal Transplant.

"Oliver Schein, M.D., M.P.H., is the Burton E. Grossman Professor of Ophthalmology at the Wilmer Eye Institute and carries a joint appointment in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Dr. Schein's clinical expertise is in medical and surgical conditions of the anterior segment of the eye including cataract and complications of cataract surgery, corneal scarring and corneal surgery. He is a past author of the American Academy of Ophthalmology's ""Preferred Practice Pattern"" on Cataract. Research activities are directed toward the epidemiology of major ocular diseases, ophthalmic technology assessment and outcomes research in ophthalmology. Dr. Schein received his M.D. and M.P.H. degrees from Johns Hopkins University and completed his ophthalmology residency and cornea and external eye disease fellowship at Harvard University's Massachusetts Eye and Ear Infirmary. He joined the Wilmer faculty in 1988.". Dr. Schein is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Cataract, Endophthalmitis, Fuchs Dystrophy, Cataract Removal, and Vitrectomy.

Isa Sayyeed Karim Mohammed is the director of refractive surgery and specializes in cornea, cataract and refractive surgery at the Wilmer Eye Institute, Johns Hopkins Medicine. He performs complex cataract surgery, corneal transplantation (penetrating keratoplasty, deep anterior lamellar keratoplasty, and descemet stripping automated endothelial keratoplasty and descemet membrane endothelial keratoplasty) and the entire range of refractive surgery, including laser-assisted in situ keratomileusis, photorefractive keratectomy and implantable collamer lenses surgery. Dr. Mohammed earned an undergraduate degree in biomedical engineering at The Johns Hopkins University and then received his medical doctorate from the University of Maryland School of Medicine. He completed an ophthalmology residency at the University of Maryland Medical Center, where he received both the Outstanding Resident Award and the Malouf Resident Research Award for excellence in research. He then completed more subspecialty training in cornea and refractive surgery at the renowned Cole Eye Institute at the Cleveland Clinic. Dr. Mohammed is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Keratoconus, Interstitial Keratitis, Leber Hereditary Optic Neuropathy (LHON), and Embolectomy.

Tazeen Rehman is a Rheumatologist in Baltimore, Maryland. Dr. Rehman is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Fibromyalgia.

Bansari Gujar is a Rheumatologist in Baltimore, Maryland. Dr. Gujar is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Rheumatoid Arthritis (RA), Fibromyalgia, Psoriatic Arthritis, and Psoriasis.

Seema Patel is a Rheumatologist in Baltimore, Maryland. Dr. Patel has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Rheumatoid Arthritis (RA), and Discoid Lupus Erythematosus (DLE).

John Baer is an Ophthalmologist in Lutherville, Maryland. Dr. Baer is rated as an Experienced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Cataract, Pigment-Dispersion Syndrome, Glaucoma, and Blepharitis.

"Irene Kuo has been designated one of America's top ophthalmologists, and received the Patient's Choice Award. She is a fellow of the American Academy of Ophthalmology and a member of the Cornea Society, an honorary society to which membership is based on a thesis and publications. She serves as president (2023-24) of the Ocular Microbiology and Immunology Group, an international group of ophthalmologists and scientists dedicated to studying ocular infections and inflammatory conditions. Dr. Kuo is co-investigator of the National Institutes of Health/National Eye Institute-funded Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US Project (CEV-US), which produces gold-standard Cochrane systematic reviews of treatments for eye diseases and conditions for stakeholders including patients, doctors and policymakers. She is an examiner for the American Board of Ophthalmology, and is on the editorial boards of Ophthalmology Science, Translational Vision Science and Technology (a journal of the Association for Research in Vision and Ophthalmology) and Cornea Open, the open access journal accompanying Cornea, the official journal of the Cornea Society. Dr. Kuo received her doctor of medicine degree from the University of California, San Francisco and completed her ophthalmology residency at the University of Southern California's Doheny Eye Institute. She then completed a fellowship in cornea, refractive surgery, and uveitis at the University of California, San Francisco. As chief of infection control for the Wilmer Eye Institute, Dr. Kuo worked with the occupational health, virology and hospital epidemiology and infection control departments to develop a policy to quickly diagnose employees who have a highly contagious and damaging form of viral conjunctivitis (""pink eye"") so they can be sent home and not infect patients and other employees.". Dr. Kuo is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Conjunctivitis (Pink Eye), Cataract, Pterygium, Dry Eye Syndrome, and Cataract Removal.

Nakul Shekhawat, M.D., M.P.H. is an ophthalmologist and eye surgeon at the Johns Hopkins Wilmer Eye Institute and the 2023 Stephen F Raab and Mariellen Brickley-Raab Rising Professor of Ophthalmology. He specializes in cataract surgery, complex cataract and anterior segment surgery, corneal and external diseases, and corneal surgery including both full- and partial-thickness corneal transplantation (DMEK, DSAEK, DALK, PKP). Dr. Shekhawat received his M.D. degree from Vanderbilt University School of Medicine and his M.P.H. degree in epidemiology and biostatistics from the Johns Hopkins Bloomberg School of Public Health. He completed ophthalmology residency at the renowned Kellogg Eye Center, University of Michigan where he received the Resident Excellence Award from the American Society of Cataract and Refractive Surgery. He completed additional subspecialty training in cornea, external disease, and refractive surgery at the Wilmer Eye Institute where he was awarded the prestigious Claes Dohlman Award from Harvard Medical School recognizing the most outstanding cornea fellow in the country. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Shekhawat_CV.pdf Recent News Articles and Media Coverage Laser cataract surgery now offered in Bethesda- Hopkins Medicine (April 2024) Johns Hopkins, Microsoft Extend Collaboration for Startups as Newest Grant Recipients Named - Johns Hopkins Technology Ventures (July 2021) Taking a Wide View with Nakul Shekhawat - Hopkins Medicine (September 2020) A Patient’s Guide to Shingles: Prompt treatment is crucial to avoid severe neurological complications - US News & World Report (January 2020) Shingle White Female: Study finds three-fold increase in number of Americans diagnosed with shingles - The Ophthalmologist (July 2019). Dr. Shekhawat is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Interstitial Keratitis, Cataract, Amebiasis, Cataract Removal, and Vitrectomy.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Samuel C. Yiu, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, specializing in cornea and external eye diseases, cataracts and refractive surgery (LASIK). In addition, he is a nationally and internationally recognized specialist in ocular surface diseases and ocular surface reconstruction surgery. Dr. Yiu received his M.Sc. (applied biometry) and Ph.D. (physiology and biophysics) from the University of Southern California. He then completed a post-doctoral fellowship in lacrimal physiology at the Schepens Eye Institute at Harvard Medical School and went on to earn his M.D. from the University of Alberta in Canada. Dr. Yiu completed an internship and his ophthalmology residency at Dalhousie University in Halifax, Nova Scotia and a fellowship in cornea, external disease and refractive surgery at the University of Southern California’s Doheny Eye Institute. After serving as the director of Doheny’s Ocular Surface Center and co-director of Doheny’s cornea division, Dr. Yiu joined the Wilmer faculty in 2011 and spent two years as the chief of the cornea division at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Riyadh, Saudi Arabia, before returning to Baltimore in 2013. Dr. Yiu is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Cataract, Interstitial Keratitis, Dry Eye Syndrome, and Cloudy Cornea.

Clarke Nelson is an Ophthalmologist in Lutherville, Maryland. Dr. Nelson is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Cataract, Chalazion, Eyelid Bump, and Glaucoma.

Donna Booth is an Ophthalmologist in Lutherville Timonium, Maryland. Dr. Booth is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Cataract, Dry Eye Syndrome, Glaucoma, and Ocular Hypertension (OHT).